To compare the efficacy of first line Bevacizumab plus chemotherapy with chemotherapy alone in patients with metastatic colorectal cancer: an observational, cohort study

Trial Profile

To compare the efficacy of first line Bevacizumab plus chemotherapy with chemotherapy alone in patients with metastatic colorectal cancer: an observational, cohort study

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms GRETA
  • Most Recent Events

    • 16 Oct 2017 New trial record
    • 12 Oct 2017 Results presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top